ClinicalTrials.gg
Active, not recruitingNCT06806007Updated Feb 3, 2025

Incentive Spirometer Training and Oropharyngeal Motor Training for Pulmonary Dysfunction in Spastic Diplegic Children

An Early Phase 1 interventional study of Group A and Group B in Pulmonary Dysfunction and Spastic Diaplegia, sponsored by Kafrelsheikh University. Active, not recruiting at 2 sites in Egypt. Open to participants aged 3 Years to 7 Years. Per ClinicalTrials.gov, last updated 2025-02-03.

Sponsored by Kafrelsheikh University · Early Phase 1, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Aug 2025, 1 year 1 month ago, but the record still lists the study as active, not recruiting.
  • Registered 3 months after the study started (first participant enrolled Oct 2024, registered Jan 2025).
Phase
Early Phase 1
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
3 Years to 7 Years
Sex
All
01

Study summary

Purpose of the study to determine the impact of incentive spirometer training and the oropharyngeal motor training or the combination of both for pulmonary dysfunction in spastic diplegic children

Read the detailed description

This is a prospective randomized controlled clinical trial, conducted at Kafr El sheikh Hospital.

  • Forty-eight children of both genders.
  • The study will include children (age 3-7 years) post selective pulmonary dysfunction.
  • Children meeting the inclusion criteria will be randomly assigned to one of three groups:
  • first Experimental Group: children in this group will receive incentive spirometer training.
  • second Experimental Group:children in this group will receive oropharyngeal motor training. .
  • third experimental Group: Patients in this group will receive combination of incentive spirometer training and oropharyngeal motor training
  • Randomization will be achieved using computer-generated random numbers to ensure an equal distribution of patients between the two groups.

Conditions: Cerebral Palsy

02

Conditions studied

  • Pulmonary Dysfunction
  • Spastic Diaplegia

Keywords

  • Pulmonary dysfunction
03

In context

Lead sponsor

Kafrelsheikh University is the lead sponsor of 291 studies on the registry; 112 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 7 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • the children with spastic CP between the age from 3 to 7 years old.

Level I to IV on the gross motor function classification system (GMFCS) , who have the partial ability to maintain antigravity head and trunk postures.

  • Cognitive and cooperative function allowing pulmonary function measurements.
  • No history of psychiatric or neurological disorders rather than cp.

Exclusion criteria

Exclusion Criteria:

  • Any uncontrolled clinically significant medical conditions such as coexistent cardiac disease or respiratory disease
  • Children with cognitive impairment who are unable to comply with the protocol required procedure
  • Children who are taking medications that can affect respiratory function
  • Children with presence or history of tracheostomy
05

Study design

Phase
Early Phase 1
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
48 participants (estimated)

Study arms

  • Experimental
    Group A : Will include 16 spastic diplegic Children suffer from pulmonary dysfunction from both gend

    Each child in the group A will receive the incentive spirometer training , attending three sessions per week for three consecutive months. The duration of the session will be half an hour Set up 1. Begin bothering child sit on the mat or chair. 2. Hold the incentive spirometer in an upright position. 3. The child Breathe out normally. 4. Place the spirometer mouthpiece in child's mouth and ask him to close his / her lips tightly around it. 5. Ask the child to Breathe in through mouth as slowly and deeply as he can, 6. Hold breath for as long as possible, or at least five seconds. Exhale slowly 7. Rest for a few seconds, and then repeat the first five steps at least 10 times every hour you're awake. 8. After each set of 10 deep breaths, ask child cough deeply to clear lungs

    Device: Group A

  • Experimental
    Group B :Will include 16 spastic diplegic Children suffer from pulmonary dysfunction from both gende

    Each child in the group B will receive the oropharyngeal motor training programme , attending three sessions per week for three consecutive months. The duration of the session will be an hour The training programme consists of 10 individual mobilization exercises involving orofacial and pharyngeal area that required 45 minutes Each exercise had to be repeated for 10 times. The 10 exercises are: * Exercise 1: Pushing Up The Tongue * Exercise 2: Touching Nose * Exercise 3: Touching Chin * Exercise 4: Pushing Tongue Right and Left * Exercise 5: Folding Tongue * Exercise 6: Clicking the Tongue * Exercise 7: Pushing Tongue Against Spoon * Exercise 8: Holding A Spoon * Exercise 9: Holding Button with Lips * Exercise 10: Gargling

    Other: Group B

  • Experimental
    Group C : Will include 16 spastic diplegic Children suffer from pulmonary dysfunction from both gend

    Each child in the group C will receive a combination program of the incentive spirometer training and oropharyngeal motor training programme attending three sessions per week for three consecutive months. The duration of the session will be one hour and half that Will be designed into half an hour for the incentive spirometer training and an hour for the oropharyngeal motor training programme

    Combination Product: Group C

Interventions

  • DeviceGroup A

    Each child in the group A will receive the incentive spirometer training , attending three sessions per week for three consecutive months. The duration of the session will be half an hour Set up 1. Begin bothering child sit on the mat or chair. 2. Hold the incentive spirometer in an upright position. 3. The child Breathe out normally. 4. Place the spirometer mouthpiece in child's mouth and ask him to close his / her lips tightly around it. 5. Ask the child to Breathe in through mouth as slowly and deeply as he can, 6. Hold breath for as long as possible, or at least five seconds. Exhale slowly 7. Rest for a few seconds, and then repeat the first five steps at least 10 times every hour you're awake. 8. After each set of 10 deep breaths, ask child cough deeply to clear lungs

  • OtherGroup B

    Each child in the group B will receive the oropharyngeal motor training programme , attending three sessions per week for three consecutive months. The duration of the session will be an hour The training programme consisted of 10 individual mobilization exercises involving orofacial and pharyngeal area that required 45 minutes Each exercise had to be repeated for 10 times. The 10 exercises are: * Exercise 1: Pushing Up The Tongue * Exercise 2: Touching Nose * Exercise 3: Touching Chin * Exercise 4: Pushing Tongue Right and Left * Exercise 5: Folding Tongue * Exercise 6: Clicking the Tongue * Exercise 7: Pushing Tongue Against Spoon * Exercise 8: Holding A Spoon * Exercise 9: Holding Button with Lips * Exercise 10: Gargling

  • Combination productGroup C

    Each child in the group C will receive a combination program of the incentive spirometer training and oropharyngeal motor training programme attending three sessions per week for three consecutive months. The duration of the session will be one hour and half that Will be designed into half an hour for the incentive spirometer training and an hour for the oropharyngeal motor training programme

06

What researchers measure

Primary outcomes

  1. forced vital capacity (FVC)

    1\) By using digital incentive spirometry which is the amount of air that an individual is able to forcibly exhale from his / her lungs after taking the deepest breath they can.

    Time frame: Two months

  2. forced expiratory volume at 1 s (FEV1)

    1\) By using digital incentive spirometry refers to the air an individual can exhale during a forced breath in 1 second

    Time frame: Two months

  3. FVC/FEV1 ratio

    1\) By using digital incentive spirometry refers to the air an individual can exhale during a forced breath in 1 second

    Time frame: Two months

  4. expiratory reserve volume (ERV)

    1\) By using digital incentive spirometry the amount of extra air above normal that you exhale during a forceful breath out.

    Time frame: Two months

  5. Peak expiratory flow (PEF)

    the volume of air forcefully expelled from the lungs in one quick exhalation

    Time frame: Two months

  6. forced expiratory flow (FEF)

    the speed that someone can breathe out air from their lungs, measured in the middle of a hard, fast breath out.

    Time frame: Two months

  7. tidal volume (TV)

    refers to the air an individual can exhale during a forced breath in 1 second

    Time frame: Two months

  8. inspiratory reserve volume (IRV)

    the additional volume of air that can be inspired at the end of a normal or tidal inspiration

    Time frame: Two months

  9. the orofacial myofunctional clinical evaluation

    the OMES protocol is an instrument for the clinical evaluation of orofacial structures and functions of children that will permit the examiner to express numerically his perception of the characteristics and behaviors observed, and that can be administered without special equipment and in a brief manner

    Time frame: Two months

07

Study locations

2 sites
  • Faculty of physical therapy Kafrelsheikh University
    Kafrelsheikh, KafrelsheikhU, Egypt
  • Faculty of physical therapy Kafrelsheikh University
    Kafrelsheikh, Kafrelsheikh, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06806007
Responsible party
Alaa Ebrahim Ahmed Mohammed Elshamy (Bachelor's degree, Kafrelsheikh University) — Principal investigator
First posted
Feb 3, 2025
Start date
Oct 15, 2024
Primary completion
Aug 30, 2025 (estimated)
Completion
Oct 1, 2025 (estimated)
Last update
Feb 3, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion